Enalapril Maleate and Hydrochlorothiazide (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Enalapril Maleate and Hydrochlorothiazide drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
NON-PROPRIETARY NAME: | Enalapril Maleate and Hydrochlorothiazide |
SUBSTANCE NAME: | ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2001-09-18 |
END MARKETING DATE: | 0000-00-00 |
Enalapril Maleate and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
Item Description | Enalapril Maleate and Hydrochlorothiazide from Taro Pharmaceuticals U.S.A., Inc. |
LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 12.5(mg/1; mg/1) |
START MARKETING DATE: | 2001-09-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51672-4045_e8d729a3-ecb4-47db-b033-fcb329d20032 |
PRODUCT NDC: | 51672-4045 |
APPLICATION NUMBER: | ANDA075788 |
Other ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: